An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses.

Lin, Hao; Zhang, Jie; Dong, Shaobo; Liu, Yaning; Liu, Peipei; Gao, George F; Liu, William J; Wu, Guizhen

Lin, Hao; Zhang, Jie; Dong, Shaobo; Liu, Yaning; Liu, Peipei; Gao, George F; Liu, William J; Wu, Guizhen.

Afiliação

Lin H; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220
Zhang J; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220
Dong S; Macheng Center for Disease Control and Prevention, Huanggang 438300, China.
Liu Y; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220
Liu P; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220
Gao GF; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220
Liu WJ; Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
Wu G; National Health Commission Key Laboratory of Biosafety, Research Units of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 10220

Biosaf Health ; 4(3): 179-185, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35505811